LIMS & Lab Automation
Enhanced software for analytical data management
ACD/Labs has introduced the v2023 software applications on the Spectrus® Platform, enhancing analytical data handling and knowledge management. The latest release focuses on improving structure characterisation, analytical data management, and data sharing with third-party applications.
Andrew Anderson, Vice President of Innovation and Informatics Strategy at ACD/Labs, expressed their commitment to anticipating the R&D community’s needs. This release aims to streamline scientists’ workflows, reduce repetitive tasks, and maximise the value of analytical data.
The v2023 software update brings several advancements:
In the realm of NMR (Nuclear Magnetic Resonance), an updated PubChem library provides quicker structure identification, support for external standard quantitative NMR studies, improved reporting for complex projects, and expedited computer-assisted structure elucidation (CASE). For Mass Spectrometry (MS), it introduces a display of all relevant information in mass spectral searches, an expanded range of quantitation options, and greater ease and flexibility in peak naming. Chromatography support is also enhanced, now including Agilent’s OpenLab, along with improved capabilities to ease method transfer between instruments and laboratories.
Moreover, v2023 improves data management by allowing scientists to review, compare, and edit analytical results across multiple experiments. It also offers expanded search options and enhanced record set management. To meet the needs of data scientists, this release expands data export capabilities, enabling the export of NMR and xC/UV/MS data to the interoperable and machine-readable JSON format. This announcement follows the recent release of v2023 Percepta software and foreshadows further expansions in the Spectrus JS portfolio later this quarter. More information online:
ilmt.co/PL/ymwG
61196pr@reply-direct.com
Automated liquid handler offers enhanced precision and effi ciency
The new generation of Eppendorf’s epMotion automated liquid handler comes with a range of enhancements focussed on enhancing user experience while maintaining trusted performance, the device will continue to offer flexibility, a wide range of accessories, and an extensive selection of available methods.
With its user-friendly interface and customisable protocols, the epMotion automated liquid handler provides exceptional precision and accuracy in liquid handling. The latest design features a sleek, compact form and improved ergonomics for comfortable and efficient use.
“We are thrilled to unveil the new epMotion, which represents the next generation of Eppendorf’s automated liquid handling portfolio,” said Dr Josef Lott, Product Manager Automation at Eppendorf. “We have developed a liquid handler that makes implementation of automation in laboratory workflows easier than ever before, and we are confident that the new epMotion will become an invaluable tool in your laboratory.”
The latest epMotion automated liquid handler is the inaugural Eppendorf instrument to showcase the company’s new product design. This design will serve as the visual identity for upcoming Eppendorf products.
More information online:
ilmt.co/PL/XA4V 59881pr@reply-direct.com
Document Management System for life sciences collaboration and compliance
Kivo has introduced Kivo GO, a unified platform designed to facilitate efficient collaboration for emerging life sciences teams while maintaining compliance and security.
Emerging companies managing new drugs and devices often find themselves navigating a complex landscape of trials and approvals, with stringent compliance requirements from regulatory authorities. Their Regulatory, Clinical, and Quality teams face significant challenges due to patchwork systems, manual processes, and unnecessary delays. A recent McKinsey study has quantified the cost of each day of delay at $1 million in lost potential revenue.
Toban Zolman, the CEO of Kivo, emphasises the critical importance of time-to-market for new treatments, both for the patients who need them and the companies sponsoring these innovations. Smaller Regulatory, Clinical, and Quality teams often lack the budget and administrative resources for large-scale enterprise solutions, leading to considerable time losses in managing documents and processes compliantly.
To address these challenges, Kivo GO offers a compliant collaboration solution equipped with integrated modules for functions such as RIM, eTMF, and QMS. Kivo GO offers several significant advantages.
Kivo GO streamlines collaboration for Regulatory, Clinical, and Quality teams, as well as partners and vendors, within a secure workspace, eliminating the need for complex integrations. Designed and priced with smaller teams in mind, Kivo GO provides an all-in-one solution at an affordable price, offering fast setup, lifetime updates, and real-time support. Every team member can access the same workspace and functional modules. Kivo GO places a strong emphasis on best-in-class security and compliance. It is Part 11 Compliant and Validated, requiring no local installation and offering built- in support for Single Sign-On. Kivo, as a fit-for-purpose, cloud-based system, is equipped with automatic guardrails and audit trails to ensure data integrity and compliance.
The launch of Kivo GO also marks the expansion of Kivo’s Quality Management (QMS) capabilities, introducing new modules for SOPs, Controlled Documents, Training, CAPAs, Vendor Management, Audits, and more. These modules leverage templates, workflows, reporting, and project management features integrated into the Kivo GO platform.
Kivo GO is not limited to in-house teams. It extends its capabilities to vendors and partners, allowing CROs and regulatory consultants to standardise their process and project management. This enables them to work more efficiently and consistently with sponsor teams.
More information online:
ilmt.co/PL/9j51 61438pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44
